Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: Q BIOMED INC.
CIK: 1596062
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2014-04-11
Last Filing Date: 2023-06-23
SEC Filings
Start End Frame Filed ACCN Value View
2019-06-01 2019-08-31 CY2018Q3 2019-10-15 0001104659-19-054220 $ 14,756,302 View
2018-12-01 2019-11-30 CY2018 2020-02-28 0001104659-20-027119 $ 15,040,513 View
2016-03-01 2016-05-31 CY2015Q2 2016-07-07 0001424884-16-000241 $ 8,721,511 View
2016-06-02 2016-08-31 CY2015Q3 2016-10-17 0001424884-16-000254 $ 8,909,414 View
2015-12-01 2016-11-30 CY2015 2017-02-28 0001424884-17-000008 $ 8,861,212 View
2016-12-01 2017-02-28 CY2016Q1 2017-04-21 0001424884-17-000030 $ 9,472,250 View
2017-03-01 2017-05-31 CY2016Q2 2017-07-20 0001424884-17-000059 $ 9,920,456 View
2017-06-01 2017-08-31 CY2016Q3 2017-10-18 0001424884-17-000083 $ 10,816,282 View
2016-12-01 2017-11-30 CY2016 2018-02-28 0001654954-18-001966 $ 10,466,648 View
2017-12-01 2018-02-28 CY2017Q1 2018-04-16 0001654954-18-003974 $ 12,727,442 View
2018-03-01 2018-05-31 CY2017Q2 2018-07-18 0001654954-18-007795 $ 13,982,627 View
2013-12-01 2014-02-28 CY2014Q1 2014-04-11 0001393905-14-000182 $ 2,000,000 View
2014-03-01 2014-05-31 CY2014Q2I 2014-07-15 0001393905-14-000406 $ 2,000,000 View
2013-12-01 2014-11-30 CY2014 2015-02-27 0001393905-15-000084 $ 2,568,493 View
2014-12-01 2015-02-28 CY2015Q1 2015-04-14 0001393905-15-000191 $ 3,250,000 View
2018-06-01 2018-08-31 CY2017Q3 2018-10-19 0001654954-18-011384 $ 14,019,683 View
2017-12-01 2018-11-30 CY2017 2019-03-07 0001144204-19-012723 $ 13,735,134 View
2018-12-01 2019-02-28 CY2018Q1 2019-04-17 0001524829-19-000007 $ 14,404,289 View
2019-03-01 2019-05-31 CY2018Q2 2019-07-19 0001144204-19-035232 $ 14,577,312 View
2019-12-01 2020-02-29 CY2019Q1 2020-04-13 0001104659-20-045973 $ 20,311,768 View
2020-03-01 2020-05-31 CY2019Q2 2020-07-15 0001104659-20-083773 $ 22,174,051 View
2020-06-01 2020-08-31 CY2020Q3 2020-10-14 0001104659-20-114948 $ 22,433,141 View
2019-12-01 2020-11-30 CY2020 2021-03-01 0001104659-21-029985 $ 22,160,426 View
2020-12-01 2021-02-28 CY2021Q1 2021-04-14 0001104659-21-050307 $ 24,644,761 View
2021-03-01 2021-05-31 CY2021Q2 2021-07-15 0001104659-21-092603 $ 26,283,700 View
2021-06-01 2021-08-31 CY2020Q3 2021-10-15 0001104659-21-126758 $ 27,660,616 View
2014-12-01 2015-11-30 CY2014 2016-03-15 0001424884-16-000219 $ 9,067,839 View
2015-12-01 2016-02-29 None 2016-04-22 0001424884-16-000234 $ 8,665,290 View
2015-12-01 2016-02-29 CY2015Q1 2016-04-25 0001424884-16-000236 $ 8,665,290 View
2014-06-01 2014-08-31 CY2014Q3I 2014-10-15 0001393905-14-000560 $ 3,019,022 View
2015-03-01 2015-05-31 CY2015Q2 2015-07-15 0001393905-15-000357 $ 3,695,652 View
2015-06-01 2015-08-31 CY2015Q3 2015-10-20 0001424884-15-000154 $ 9,801,630 View
2020-12-01 2021-11-30 CY2021Q4I 2022-02-28 0001410578-22-000230 $ 10,000,000 View
2022-03-01 2022-02-01 CY2022Q1I 2022-04-14 0001410578-22-000915 $ 17,000 View
2022-03-01 2022-05-31 CY2022Q2 2022-07-28 0001410578-22-001992 $ 118,012 View
2022-06-01 2022-08-31 CY2022Q3 2022-11-03 0001410578-22-002927 $ 382,072 View
2022-12-01 2023-02-28 CY2023Q1 2023-06-23 0001410578-23-001458 $ -276,602 View
2021-12-01 2022-11-30 CY2022 2023-05-26 0001410578-23-001376 $ 118,000 View
SEC Facts By Type
Type Name Description View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Payments for Repurchase of Equity The cash outflow to reacquire common and preferred stock. View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Amortization The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. View
us-gaap Adjustment of Warrants Granted for Services Adjustment for noncash service expenses paid for by granting of warrants. View
us-gaap Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
us-gaap Accelerated Share Repurchases, Settlement (Payment) or Receipt Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Payable Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Accounts Payable, Related Parties, Current Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Broker Dealer, Securities Owned Not Readily Marketable, at Estimated Fair Value (Deprecated 2016-01-31) Total amount of debt instruments issued by a government or entity guaranteeing payment of the original investment plus interest by a specified future date, corporate stocks (common, preferred), representing ownership rights in an entity or other legal entity, and stock options, warrants, and any other financial instrument which represents or provides the ability to obtain ownership rights in an Entity or other legal entity which financial instruments are not readily marketable for reasons including, but not necessarily limited to: (a) no market on a securities exchange or no independent publicly quoted market; (b) not able to be publicly offered for sale or sold unless a registration has been effected under existing securities laws; or (c) not able to be offered for sale or sold because of other arrangements, restrictions, or conditions applicable to the securities or to the broker-dealer. View
us-gaap Business Combination, Acquisition Related Costs This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. View
us-gaap Banking Regulation, Total Capital, Actual Amount of total capital as defined by regulatory framework. View
us-gaap Capital Expenditure, Discontinued Operations Amount of capital expenditure attributable to discontinued operations. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Unissued The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights. View
us-gaap Common Stock, Capital Shares Reserved for Future Issuance Aggregate number of common shares reserved for future issuance. View
us-gaap Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Contract with Customer, Liability, Current Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. View
us-gaap Conversion of Stock, Amount Issued "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Conversion of Stock, Shares Issued "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Convertible Debt, Noncurrent Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Convertible Notes Payable Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. View
us-gaap Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Converted Instrument, Shares Issued "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or payments in the period." View
us-gaap Long-term Debt, Gross Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. View
us-gaap Debt Instrument, Convertible, Conversion Price The price per share of the conversion feature embedded in the debt instrument. View
us-gaap Debt Instrument, Convertible, Conversion Ratio Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount. View
us-gaap Debt Instrument, Convertible, Threshold Consecutive Trading Days Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Debt Instrument, Unamortized Discount, Current Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer. View
us-gaap Debt Instrument, Unamortized Discount, Noncurrent Amount of debt discount to be amortized after one year or the normal operating cycle, if longer. View
us-gaap Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. View
us-gaap Deferred Tax Assets, Charitable Contribution Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible charitable contribution carryforwards. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Other Loss Carryforwards Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible loss carryforwards, classified as other. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. View
us-gaap Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on available-for-sale securities. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) Cumulative net losses reported during the development stage. View
us-gaap Dividends, Preferred Stock Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Percent Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Deduction, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. View
us-gaap Effective Income Tax Rate Reconciliation, Deduction, Other, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Fair Value Inputs, Comparability Adjustments (Deprecated 2018-01-31) Percentage of adjustment to the observed price for a similar asset or liability when an identical transaction does not exist, used as an input to measure fair value. View
us-gaap Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Issuances (Deprecated 2019-01-31) Amount of issuances of financial instrument classified in shareholders' equity measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) Amount of increase (decrease) of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. View
us-gaap Gain (Loss) on Non-Recourse Debt Amount represents the difference between the cash acquisition price of the debt and the net carrying amount of the debt at the time of its extinguishment (or deconsolidation of in-substance real estate when an entity defaults on its debt obligations). View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Held-to-maturity, Securities in Unrealized Loss Positions, Qualitative Disclosure, Other, Fair Value Volatility, Rate This item represents the volatility rate related to the fair value of the underlying assets in the security, represented as a percentage, which was considered as one of the potential factors in reaching a conclusion that the held-to-maturity investments are not other-than-temporarily impaired. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. View
us-gaap Income Taxes Paid, Net The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Accrued Taxes Payable The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes. View
us-gaap Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Increase (Decrease) in Prepaid Expenses, Other Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Written Put Options Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of outstanding written put options using the reverse treasury stock method. View
us-gaap Induced Conversion of Convertible Debt Expense Consideration given by issuer of convertible debt to provide an incentive for debt holders to convert the debt to equity securities. The expense is equal to the fair value of all securities and other consideration transferred in the transaction in excess of the fair value of securities issuable pursuant to the original conversion terms. View
us-gaap Interest and Dividends Payable, Current Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity). Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Expense, Debt Amount of the cost of borrowed funds accounted for as interest expense for debt. View
us-gaap Interest Income, Operating Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. View
us-gaap Interest Income, Other Amount of interest income earned from interest bearing assets classified as other. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Inventory Write-down Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. View
us-gaap Investments in and Advances to Affiliates, Balance, Principal Amount Amount of principal loans outstanding to affiliates for management investment companies. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Other than Long-term Debt, Noncurrent Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Net Income (Loss) Available to Common Stockholders, Basic Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. View
us-gaap Net Investment Income Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. View
us-gaap Notes and Loans Payable, Current Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Salary and Wage, Officer, Excluding Cost of Good and Service Sold Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. View
us-gaap Open Option Contracts Written, at Fair Value The fair value of the open option contracts written for the investment. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Expenses Amount of expense classified as other. View
us-gaap Other General and Administrative Expense Amount of general and administrative expense classified as other. View
us-gaap Other Nonoperating Expense Amount of expense related to nonoperating activities, classified as other. View
us-gaap Other Research and Development Expense Amount of other research and development expense. View
us-gaap Partners' Capital Account, Private Placement of Units Monetary value of the issuance of new units of limited partnership interest in a private placement. View
us-gaap Partners' Capital Account, Units, Sold in Private Placement The number of units sold in a private placement of each class of partners' capital account. Units represent shares of ownership of the general, limited, and preferred partners. View
us-gaap Partners' Capital Other Deferred Compensation (Deprecated 2016-01-31) The amount of partners' deferred compensation which is a component of 'Other Comprehensive Income' that is not otherwise defined. All partners include general, limited and preferred partners. Limited liability partnerships (LLPs) are formed in accordance with the laws of the state in which such entities are organized. Because those laws are not uniform, the characteristics of LLPs vary from state to state. However, LLPs generally have the following characteristics: An LLP is an unincorporated association of two or more "persons"; Its members have limited personal liability for the obligations or debts of the entity; It is classified as a partnership for federal income tax purposes. View
us-gaap Payments for Legal Settlements The amount of cash paid for the settlement of litigation or for other legal issues during the period. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Payments to Acquire in Process Research and Development The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. View
us-gaap Payments to Acquire Intangible Assets The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. View
us-gaap Preferred Stock, Dividend Rate, Percentage The percentage rate used to calculate dividend payments on preferred stock. View
us-gaap Preferred Stock Dividends, Income Statement Impact The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. View
us-gaap Preferred Stock, No Par Value Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Contributed Capital The cash inflow associated with the amount received by a corporation from a shareholder during the period. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Convertible Preferred Stock The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Proceeds from Issuance of Medium-term Notes The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years. View
us-gaap Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. View
us-gaap Proceeds from Issuance of Secured Debt The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Redeemable Preferred Stock Dividends Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer. View
us-gaap Related Party Transaction, Expenses from Transactions with Related Party Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. View
us-gaap Repayments of Related Party Debt The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. View
us-gaap Research and Development Expense The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. View
us-gaap Research and Development Expense (Excluding Acquired in Process Cost) The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. View
us-gaap Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Sales Revenue, Services, Net (Deprecated 2018-01-31) Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. View
us-gaap Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Stockholders' Equity, Other This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy. View
us-gaap Stockholders' Equity, Other Shares Number of increase (decrease) in shares of stock classified as other. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average price of options that were either forfeited or expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average price at which option holders acquired shares when converting their stock options into shares. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. View
us-gaap Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Shares, Issued Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. View
us-gaap Shares Issued, Price Per Share Per share or per unit amount of equity securities issued. View
us-gaap Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury. View
us-gaap Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Value of preferred stock and warrants for common stock issued. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) Number of shares issued as consideration for cash for development stage entities. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Stock Issued During Period, Value, Conversion of Units Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). View
us-gaap Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) Value of shares issued as consideration for cash for development stage entities. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Deferred Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. View
us-gaap Debt Conversion, Original Debt, Amount "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Instrument, Increase (Decrease), Net Net increase or decrease in the carrying amount of the debt instrument for the period. View
us-gaap Loss Contingency, Damages Sought, Value The value (monetary amount) of the award the plaintiff seeks in the legal matter. View
us-gaap Share-based Payment Arrangement, Plan Modification, Incremental Cost An excess of the fair value of the modified award over the fair value of the award immediately before the modification. View
us-gaap APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Conversion of Stock, Shares Converted "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Interest and Debt Expense Interest and debt related expenses associated with nonoperating financing activities of the entity. View
us-gaap Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Liabilities, Fair Value Adjustment Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties. View
us-gaap Preferred Stock Conversions, Inducements The excess of (1) the fair value of all securities and other consideration transferred in transactions by the registrant to the holders of the convertible preferred stock over (2) the fair value of securities issuable pursuant to the original conversion terms, during the accounting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Number of options vested. View
us-gaap Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates. View
us-gaap Interest Expense, Other Amount of interest expense classified as other. View
us-gaap Long-term Investments The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Payments to Acquire Investments The cash outflow associated with the purchase of all investments (debt, security, other) during the period. View
us-gaap Write off of Deferred Debt Issuance Cost Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt. View
us-gaap Payments for Repurchase of Private Placement The cash outflow associated with the repurchase of amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from (Repayments of) Short-term Debt The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Warrant Exercises The cash inflow associated with the amount received from holders exercising their stock warrants. View
us-gaap Administrative Fees Expense Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs. View
us-gaap Amortization of Deferred Charges The amount of amortization of deferred charges applied against earnings during the period. View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Cash, Cash Equivalents, and Short-term Investments Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Debt Instrument, Convertible, Beneficial Conversion Feature Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). View
us-gaap Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period. View
us-gaap Employee-related Liabilities, Current Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Equity, Fair Value Disclosure Fair value of the entity's equity. View
us-gaap Extended Product Warranty Accrual, Current Amount at end of the reporting period of the aggregate extended product warranty liability that is expected to be paid within one year of the balance sheet date or normal operating cycle, if longer. Does not include the balance for the standard product warranty liability. View
us-gaap Extinguishment of Debt, Gain (Loss), Net of Tax The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax. View
us-gaap Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability. View
us-gaap Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). View
us-gaap Federal Funds Sold and Securities Purchased under Agreements to Resell Includes: (1) the amount outstanding of funds lent to other depository institutions, securities brokers, or securities dealers in the form of Federal Funds sold; for example, immediately available funds lent under agreements or contracts that mature in one business day or roll over under a continuing contract, regardless of the nature of the transaction or the collateral involved, excluding overnight lending for commercial and industrial purposes. Also include Federal Funds sold under agreements to resell on a gross basis, excluding (1) sales of term Federal Funds, (2) due bills representing purchases of securities or other assets by the reporting bank that have not yet been delivered and similar instruments, (3) resale agreements that mature in more than one business day involving assets other than securities, and (4) yield maintenance dollar repurchase agreements (Federal Funds Sold) and (2) the dollar amount outstanding of funds lent in the form of security resale agreements regardless of maturity, if the agreement requires the bank to resell the identical security purchased or a security that meets the definition of substantially the same in the case of a dollar roll. Also include purchases of participations in pools of securities, regardless of maturity (Securities Purchased Under Agreements to Re-sell). View
us-gaap Financial Instruments, Owned, at Fair Value The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings. View
us-gaap Financial Instruments, Owned, Corporate Equities, at Fair Value The fair value as of the balance sheet date of firm holdings in corporate stocks (common and preferred), stock options, warrants and any other financial instrument which represents, or provides the ability to obtain, ownership rights in a corporation. Includes both pledged (to counterparties as collateral for financing transactions) and unpledged holdings. View
us-gaap Finite-Lived Intangible Assets, Net Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method. View
us-gaap Indefinite-Lived License Agreements Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit. View
us-gaap Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss) Amount of accumulated undistributed earnings (deficit) from ordinary income (loss) of investment company. View
us-gaap Investment Owned, Balance, Principal Amount For investments which are quantified by principal amount, the principle balance held at close of period. View
us-gaap Investment Owned, Loaned for Short Sales, at Fair Value (Deprecated 2020-01-31) The aggregate value of investments loaned for short sales. This is not required to be disclosed under Regulation S-X but is commonly reported by Funds. View
us-gaap Investment Owned, Unrecognized Unrealized Depreciation This element represents the excess of the cost (face amount, notional amount) of an investment (security, contract) over its fair value which deficiency has not been recognized in earnings of the entity. View
us-gaap Investment Sold, Not yet Purchased, Balance, Principal Amount For investments which are quantified by principal amount, the principle balance held at close of period. View
us-gaap Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP). View
us-gaap Long-term Debt Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. View
us-gaap Notes Issued The fair value of notes issued in noncash investing and financing activities. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Reclassifications of Temporary to Permanent Equity The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2. View
us-gaap Recorded Third-Party Environmental Recoveries, Amount Recorded amount of the individual components comprising the asset for third-party recoveries related to environmental remediation obligations. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities. View
us-gaap Temporary Equity, Shares Issued The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Debt, Current Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. View
us-gaap Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. View
Chart of Accounts => Accounts
Name View
Interest Income, Operating View
Interest Income, Other View
Proceeds from Warrant Exercises View
Professional Fees View
Interest Expense, Debt View
Accelerated Share Repurchases, Settlement (Payment) or Receipt View
Accounts Payable and Accrued Liabilities, Current View
Accounts Payable, Current View
Accounts Payable View
Accounts Payable, Related Parties, Current View
Accounts Receivable, after Allowance for Credit Loss, Current View
Accrued Liabilities, Current View
Additional Paid in Capital View
Amortization View
Amortization of Debt Discount (Premium) View
Amortization of Deferred Charges View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Broker Dealer, Securities Owned Not Readily Marketable, at Estimated Fair Value (Deprecated 2016-01-31) View
Business Combination, Acquisition Related Costs View
Banking Regulation, Total Capital, Actual View
Capital Expenditure, Discontinued Operations View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, and Short-term Investments View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Unissued View
Common Stock, Capital Shares Reserved for Future Issuance View
Common Stock, Dividends, Per Share, Declared View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Contract with Customer, Liability, Current View
Conversion of Stock, Amount Issued View
Conversion of Stock, Shares Issued View
Convertible Debt, Noncurrent View
Convertible Notes Payable View
Convertible Notes Payable, Current View
Cost of Revenue View
Debt Conversion, Converted Instrument, Amount View
Debt Conversion, Converted Instrument, Shares Issued View
Long-term Debt, Gross View
Debt Instrument, Convertible, Beneficial Conversion Feature View
Debt Instrument, Convertible, Conversion Price View
Debt Instrument, Convertible, Conversion Ratio View
Debt Instrument, Convertible, Threshold Consecutive Trading Days View
Debt Instrument, Face Amount View
Debt Instrument, Unamortized Discount View
Debt Instrument, Unamortized Discount, Current View
Debt Instrument, Unamortized Discount, Noncurrent View
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction View
Deferred Tax Assets, Charitable Contribution Carryforwards View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Other Loss Carryforwards View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities View
Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross View
Deferred Tax Assets, Valuation Allowance View
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) View
Dividends, Preferred Stock View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Effective Income Tax Rate Reconciliation, Percent View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Effective Income Tax Rate Reconciliation, Deduction, Percent View
Effective Income Tax Rate Reconciliation, Deduction, Other, Percent View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent View
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent View
Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) View
Fair Value Inputs, Comparability Adjustments (Deprecated 2018-01-31) View
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Issuances (Deprecated 2019-01-31) View
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) View
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs View
Federal Funds Sold and Securities Purchased under Agreements to Resell View
Financial Instruments, Owned, at Fair Value View
Financial Instruments, Owned, Corporate Equities, at Fair Value View
Finite-Lived Intangible Assets, Net View
Gain (Loss) on Non-Recourse Debt View
Gain (Loss) on Extinguishment of Debt View
General and Administrative Expense View
Gross Profit View
Held-to-maturity, Securities in Unrealized Loss Positions, Qualitative Disclosure, Other, Fair Value Volatility, Rate View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest View
Income Taxes Paid, Net View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accounts Receivable View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Accrued Taxes Payable View
Increase (Decrease) in Inventories View
Increase (Decrease) in Prepaid Expense View
Increase (Decrease) in Prepaid Expenses, Other View
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants View
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities View
Incremental Common Shares Attributable to Dilutive Effect of Written Put Options View
Indefinite-Lived License Agreements View
Induced Conversion of Convertible Debt Expense View
Interest and Dividends Payable, Current View
Interest Expense View
Interest Payable, Current View
Inventory Write-down View
Investments in and Advances to Affiliates, Balance, Principal Amount View
Issuance of Stock and Warrants for Services or Claims View
Operating Leases, Rent Expense View
Liabilities View
Liabilities and Equity View
Liabilities, Current View
Liabilities, Other than Long-term Debt, Noncurrent View
Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest View
Long-term Debt View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Investing Activities View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Net Income (Loss) Available to Common Stockholders, Basic View
Net Investment Income View
Notes and Loans Payable, Current View
Notes Issued View
Notes Payable, Current View
Notes Payable, Related Parties, Current View
Salary and Wage, Officer, Excluding Cost of Good and Service Sold View
Open Option Contracts Written, at Fair Value View
Operating Expenses View
Operating Income (Loss) View
Operating Loss Carryforwards View
Other Expenses View
Other General and Administrative Expense View
Other Nonoperating Expense View
Other Research and Development Expense View
Partners' Capital Account, Private Placement of Units View
Partners' Capital Account, Units, Sold in Private Placement View
Partners' Capital Other Deferred Compensation (Deprecated 2016-01-31) View
Payments for Legal Settlements View
Payments for Repurchase of Common Stock View
Payments for Repurchase of Equity View
Payments for Repurchase of Private Placement View
Payments of Stock Issuance Costs View
Payments to Acquire in Process Research and Development View
Payments to Acquire Intangible Assets View
Preferred Stock, Dividend Rate, Percentage View
Preferred Stock Dividends, Income Statement Impact View
Preferred Stock, No Par Value View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Contributed Capital View
Proceeds from Convertible Debt View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Convertible Preferred Stock View
Proceeds from Issuance of Medium-term Notes View
Proceeds from Issuance of Preferred Stock and Preference Stock View
Proceeds from Issuance of Secured Debt View
Proceeds from Issuance of Warrants View
Proceeds from Issuance or Sale of Equity View
Proceeds from Notes Payable View
Proceeds from Related Party Debt View
Proceeds from (Repayments of) Short-term Debt View
Related Party Transaction, Expenses from Transactions with Related Party View
Repayments of Related Party Debt View
Research and Development Expense View
Research and Development Expense (Excluding Acquired in Process Cost) View
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings View
Retained Earnings (Accumulated Deficit) View
Revenues View
Sale of Stock, Price Per Share View
Sales Revenue, Services, Net (Deprecated 2018-01-31) View
Selling, General and Administrative Expense View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable View
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price View
Share Price View
Shares, Issued View
Shares Issued, Price Per Share View
Shares, Outstanding View
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants View
Stockholders' Equity Attributable to Parent View
Stockholders' Equity, Other View
Stockholders' Equity, Other Shares View
Stock Issued View
Stock Issued During Period, Shares, Acquisitions View
Stock Issued During Period, Shares, Conversion of Convertible Securities View
Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Stock Issued During Period, Value, Conversion of Units View
Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Stock Options Exercised View
Temporary Equity, Shares Issued View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Deferred Tax Assets, Net View
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration View
Debt Conversion, Original Debt, Amount View
Debt, Current View
Debt Instrument, Increase (Decrease), Net View
Loss Contingency, Damages Sought, Value View
Share-based Payment Arrangement, Plan Modification, Incremental Cost View
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition View
Share-based Payment Arrangement, Expense View
Conversion of Stock, Shares Converted View
Derivative Liability, Current View
Interest and Debt Expense View
Inventory, Net View
Liabilities, Fair Value Adjustment View
Preferred Stock Conversions, Inducements View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares View
Unrealized Gain (Loss) on Derivatives View
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration View
Interest Expense, Other View
Long-term Investments View
Other Nonoperating Income (Expense) View
Payments to Acquire Investments View
Write off of Deferred Debt Issuance Cost View
Adjustment of Warrants Granted for Services View
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Administrative Fees Expense View
Deferred Tax Assets, Operating Loss Carryforwards View
Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent View
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net View
Employee-related Liabilities, Current View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Equity, Fair Value Disclosure View
Extended Product Warranty Accrual, Current View
Extinguishment of Debt, Gain (Loss), Net of Tax View
Fair Value Adjustment of Warrants View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Investment Company, Distributable Earnings (Loss), Accumulated Ordinary Income (Loss) View
Investment Owned, Balance, Principal Amount View
Investment Owned, Loaned for Short Sales, at Fair Value (Deprecated 2020-01-31) View
Investment Owned, Unrecognized Unrealized Depreciation View
Investment Sold, Not yet Purchased, Balance, Principal Amount View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Reclassifications of Temporary to Permanent Equity View
Recorded Third-Party Environmental Recoveries, Amount View
Redeemable Preferred Stock Dividends View
Stock Issued During Period, Value, Other View